Login

AES CEO Andrés Gluski discusses his company's strategy for using renewable energy methods to power data centers in an interview with Alix Steel. 00:10:00

Share On Facebook Share On Twitter

Rogerio Jorge is the CEO of AES Brasil.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Avoiding Tax Pitfalls: Navigating LLCs for Canadian Businesses in the U.S.
00:10:00
From Bricklayer to Wallman: Revolutionizing an Ancient Trade
00:10:00
Puuilo Faces Economic Headwinds: CEO Juha Saarela Explains Stable Customer Numbers and Stronger Sales Margins | Juha Saarela, CEO of Puuil OYj.
00:10:00
Guide to Buying Your Dream Home in Retirement | Dana Anspach, CEO , Sensible Money, LLC.
00:10:00
The Impact of Prolonged Low Interest Rates on the Market | Morgan Christen, CEO, Spinnaker Investment Group, LLC.
00:10:00
Bruce Flatt, CEO of Brookfield Asset Management, and Lubna Bouza discuss weathering inflation challenges at the FII6 conference, emphasizing Brookfield Renewable Partners' strategies.
00:10:00
Amanda Burgess on Burgex's Commitment to Accurate Landman and Claim Staking Services
00:10:00
For us, it All Started With Lending|Stephen Scutts, Managing Director of Castlerock Capital
00:10:00
Steve Klar on Asset Management's Role in Achieving Sustainable Development Goals: Balancing Returns and Positive Impact - A Discussion at the UN World Investment Forum by Force for Good
00:10:00
BigCommerce's stock has tripled since its IPO, according to CEO Brent Bellm in an interview with Ryan Detrick.|Brent is the Chief Executive Officer of BigCommerce.
00:10:00
Jonathan Nelson on the Uncertainty of Rising Interest Rates | Jonathan Nelson, CEO, Providence Equity Partners.
00:10:00
Ville Kangasmuukko on Bubbleroom's IPO Plans and E-commerce Strategy | Ville Kangasmuukko, CEO, New Bubbleroom Sweden AB.

© 2017 - Neuhu+